PMC:1472690 / 439-689 JSONTXT

{"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T302","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T303","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T304","span":{"begin":229,"end":248},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T433","span":{"begin":160,"end":167},"obj":"http://www.uniprot.org/uniprot/P06886"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"UBERON-AE","denotations":[{"id":"T187","span":{"begin":7,"end":12},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"GO-BP","denotations":[{"id":"T208","span":{"begin":13,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T209","span":{"begin":13,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T210","span":{"begin":13,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0019724"},{"id":"T211","span":{"begin":13,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0002228"},{"id":"T212","span":{"begin":13,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0002443"},{"id":"T213","span":{"begin":13,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0001909"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"GO-MF","denotations":[{"id":"T348","span":{"begin":47,"end":61},"obj":"http://purl.obolibrary.org/obo/GO_0001872"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"GO-CC","denotations":[{"id":"T356","span":{"begin":20,"end":25},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"sentences","denotations":[{"id":"T192","span":{"begin":173,"end":180},"obj":"Sentence"},{"id":"T6","span":{"begin":173,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"ICD10","denotations":[{"id":"T333","span":{"begin":133,"end":153},"obj":"http://purl.bioontology.org/ontology/ICD10/A48.3"},{"id":"T334","span":{"begin":139,"end":144},"obj":"http://purl.bioontology.org/ontology/ICD10/R57.9"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"simple1","denotations":[{"id":"T395","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T396","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T397","span":{"begin":229,"end":248},"obj":"Protein"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"BioNLP16_DUT","denotations":[{"id":"T861","span":{"begin":192,"end":202},"obj":"Positive_regulation"},{"id":"T827","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T828","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T832","span":{"begin":229,"end":248},"obj":"Protein"}],"relations":[{"id":"R341","pred":"themeOf","subj":"T832","obj":"T861"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"BioNLP16_Messiy","denotations":[{"id":"T488","span":{"begin":192,"end":202},"obj":"Positive_regulation"},{"id":"T453","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T454","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T458","span":{"begin":229,"end":248},"obj":"Protein"}],"relations":[{"id":"R250","pred":"themeOf","subj":"T458","obj":"T488"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"DLUT931","denotations":[{"id":"T606","span":{"begin":192,"end":202},"obj":"Positive_regulation"},{"id":"T573","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T574","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T578","span":{"begin":229,"end":248},"obj":"Protein"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T761","span":{"begin":68,"end":74},"obj":"Entity"},{"id":"T774","span":{"begin":133,"end":170},"obj":"Protein"},{"id":"T777","span":{"begin":13,"end":61},"obj":"Entity"},{"id":"T778","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T790","span":{"begin":229,"end":248},"obj":"Protein"},{"id":"T792","span":{"begin":102,"end":129},"obj":"Entity"},{"id":"T804","span":{"begin":125,"end":128},"obj":"Entity"},{"id":"T740","span":{"begin":68,"end":170},"obj":"Entity"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T514","span":{"begin":206,"end":227},"obj":"Protein"},{"id":"T521","span":{"begin":192,"end":202},"obj":"Positive_regulation"},{"id":"T522","span":{"begin":192,"end":202},"obj":"Positive_regulation"},{"id":"T523","span":{"begin":192,"end":202},"obj":"Positive_regulation"},{"id":"T515","span":{"begin":229,"end":248},"obj":"Protein"}],"relations":[{"id":"R263","pred":"themeOf","subj":"T514","obj":"T521"},{"id":"R264","pred":"themeOf","subj":"T515","obj":"T522"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"testone","denotations":[{"id":"T38","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T39","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T40","span":{"begin":229,"end":248},"obj":"Protein"}],"relations":[{"id":"R1","pred":"equivalentTo","subj":"T39","obj":"T38"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}

{"project":"test3","denotations":[{"id":"T100","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T101","span":{"begin":229,"end":248},"obj":"Protein"},{"id":"T99","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T135","span":{"begin":133,"end":161},"obj":"Protein"},{"id":"T136","span":{"begin":163,"end":169},"obj":"Protein"},{"id":"T137","span":{"begin":192,"end":202},"obj":"Positive_regulation"},{"id":"T138","span":{"begin":229,"end":248},"obj":"Protein"}],"relations":[{"id":"R41","pred":"equivalentTo","subj":"T136","obj":"T135"},{"id":"R42","pred":"themeOf","subj":"T138","obj":"T137"}],"text":"pheral blood immune cells mediated by a fungal β-1→3-D-glucan, i.e. glucan phosphate, in the presence of lipopolysaccharide (LPS) or toxic shock syndrome toxin 1 (TSST-1).\n\nResults\nDespite an activation of nuclear factor (NF)κB, NFinterleukin(IL)-6 a"}